THM Capital Advisory advises Advanced Life Solutions on the second tranche of its Series A financing

Advanced Life Solutions announces the raising of the second installment of its Series A, worth 2.5 million euros, in order to accelerate its development in Europe, the United States and the Middle East.

This operation is carried out with the support of THM Capital Advisory, the company's financial advisor.

Founded by Silvina Ramella, an internationally renowned scientist in organ transplantation and former CEO at one of the main European companies in the sector, Advanced Life Solutions is developing Perla®, a new liquid designed to preserve and protect grafts.

The aim of the solution is to improve the functional recovery of transplanted organs and to increase their lifespan.

Perla® responds to the structural evolution of transplants: the proportion of more fragile grafts, especially from older donors, is increasing. However, the preservation fluids used routinely in transplant services are based on formulations designed 30 to 40 years ago, whose suitability for these organs is decreasing.”Sensitive”, which are also among the most available today.

After a first installment raised in 2022, this second Series A installment will allow Advanced Life Solutions to finance its next stages of development and international deployment. The two family offices that entered into capital during the first phase (2022) are leading this new financing stage.

THM Capital Advisory supported Advanced Life Solutions throughout the operation as financial advisor (team: to be completed as soon as you give me the exact names on the THM side).

THM Capital Advisory supported the founders of Advanced Life Solutions as financial advisor, with a team composed of Thomas Mitard and Aurélien Prost, while McDermott Will & Emery (Henri Pieyre de Mandiargues) acted as legal advisor.